Please login to the form below
Therapy Area
This page shows the latest Therapy Area news and features for those working in and with pharma, biotech and healthcare.
Amgen, Cytokinetics’ heart failure drug disappoints in phase 3
Heart failure has become an increasingly competitive therapy area over the last few years, as a new generation of therapies enter the market.
Latest news
-
BMS picks up cardiovascular specialist MyoKardia for $13.1bn
The addition of MyoKardia’s pipeline cardiovascular candidates builds on BMS’ established presence in this therapy area.
-
What makes a great launch leader and launch team?
Strategic decision-making and alignment – the ability to create a compelling launch strategy adapted to the local market, therapy area, competitive context and external environment ensuring critical success factors for the ... launch. Technical skills
-
Moderna inks R&D agreements with Vertex and Chiesi
As part of that deal, Moderna will receive $25m upfront as well as a potential $400m in milestone payments to conduct research and development activities in this therapy area. ... The condition affects around two to five million adults across the globe,
-
Novartis wins FDA approval for relapsing MS drug Kesimpta
Kesimpta’s approval in relapsing MS builds on Novartis’ existing presence in the therapy area, which includes its active secondary progressive multiple sclerosis (SPMS) therapy Mayzent (siponimod).
-
Merck enters agreement with Hanmi for investigational NASH drug
As drugmakers race to bring treatments for NASH to market, the therapy area has seen a number of late-stage failures, including Gilead’s ASK1 inhibitor selonsertib and Genfit’s elafibranor.
More from news
Approximately 0 fully matching, plus 256 partially matching documents found.
Latest Intelligence
-
Why pharma must trust the science of behaviour
One area of behavioural science that can be readily transferred into the healthcare arena is nudge theory. ... It’s therefore important to invest time and resource to insight gathering; what are the truths when it comes to a brand, market/therapy area
-
The big issue
Again, think of your colleagues: compared to a generation ago, they now specialise not only by discipline but also by sub-discipline, geography and therapy area.
-
War games: why brand teams need a cunning plan that cannot fail
This typically means defining all your different audience groups, mapping out the various archetypes and personas within them, and understanding current beliefs in your therapy area. ... Pharma’s ability to factor behavioural understanding into
-
China’s homecoming heroes fuel a biotech boom with rapid CAR-T advances
Government policy amendments have accelerated the regulatory pathway, which is important as cell therapy had been a controversial area,” added Xiaofeng, who was born in China and has a PhD in ... There was no robust, regulatory control but that has
-
Why pharma should invest in the education of doctors
Given that the patent life of a drug is 10-15 years, and most companies’ pipelines contain multiple drugs in the same therapy area, it makes sense to invest in building
More from intelligence
Approximately 0 fully matching, plus 53 partially matching documents found.
Latest appointments
-
AstraZeneca taps internal candidate to become UK president
Keith-Roach joins the AZ UK team following a number of in-country, above-country and global therapy area leadership positions.
-
New hires at bluebird bio, BioNTech and Provention Bio
In her new role, Heffron will be based in Zug, Switzerland, where she will aid the launch of bluebird’s first commercial product – its gene therapy Zynteglo. ... She also spent 11 years at GlaxoSmithKline, ending her time there as vice president
-
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO
She then moved on to global project leadership and portfolio management for early development projects, before moving into late stage clinical development in the respiratory therapy area, contributing to Nucala, Incruse,
-
Concept Life Sciences adds to its scientific and commercial team
With over 17 years’ experience in the pharmaceutical industry, Dr Donaldson was most recently director of biology in dermatology therapy area at GlaxoSmithKline.
-
Bedrock Communications strengthens operations
Strengthening the agency’s medical writing capability and therapy area expertise is new addition Emily Bell, who joins Bedrock as its principal medical writer and Sarah Cripps takes up the finance
More from appointments
Approximately 0 fully matching, plus 15 partially matching documents found.
Latest from PMHub
-
Maloff Mosquito
Therapy area: OTC Products.
-
Kendle Healthcare
Kendle’s research division conducts identification projects which deliver powerful insights into the clinician landscape in any therapy area, large or small. ... Our methodology is complex, but our aim is simple: provide peace of mind by ensuring our
-
Top 5 tips for a multi-indication product launch
In our experience this is usually due to the launch of new indications, either in the same therapy area or in a new one.
-
Making a difference with patient support
The answer lies in the methodology. The specific implementation of a PSP and its key deliverables will depend on the therapy area, the drug and the audience. ... What communication channels do patients in this area prefer? Well-executed PSPs offer a
-
Delivering Medical Communications when travel is restricted: solving the 6 most common problems
5. THE KEY CONFERENCE FOR OUR DISEASE AREA, WHERE WE WERE GOING TO SHARE OUR LATEST DATA AND CONNECT WITH HCPS, HAS BEEN POSTPONED – WHAT NOW? ... 6. WE HAVE NEEDED TO CANCEL AN EDUCATIONAL MEETING FOR HEALTHCARE PROFESSIONALS, BUT THERE IS A REAL
More from PMHub
Approximately 2 fully matching, plus 81 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Relief Therapeutics’ COVID-19 drug shows positive results ahead of trial readout
- Roche and Atea link up for oral COVID-19 drug; UK to test coronavirus vaccine T cell responses
- GSK chief exec ‘optimistic’ COVID-19 vaccine could be available next year
- Pfizer CEO says COVID-19 vaccine efficacy data could come ‘soon’
- UK Vaccine Taskforce chief says first COVID-19 vaccines ‘likely to be imperfect’
- Send Us a Message
- Pharma, Technology, and Healthcare in the New Normal
- Solving the Caregiver Crisis Through Technology
- Therapeutic VR for Managing Pain & Improving Patient Outcomes
- Fishawack Health launches global ‘PsoriasIS NOT CONTAGIOUS’ mask campaign for World Psoriasis Day 2020
- The impact of COVID-19 on cancer care
- UK Vaccine Taskforce chief says first COVID-19 vaccines ‘likely to be imperfect’
PMHub
Frontera Group
Welcome to Frontera Group, where our agencies immerse you in the world of the patient...
Latest intelligence
- The science of the deal
- Business development is more like child-raising than you might think...
- The other side of … rheumatoid arthritis
- For Georgie, patient activation fuelled her motivation to find life without pain. So when blood tests came back normal, she felt confident to pursue referral until RA was confirmed......
- How to lessen site burden with a targeted patient recruitment strategy
- Picture this: you’ve created your patient recruitment strategy and you find more and more patients are undertaking the pre-screening, you probably think – success! But then you find out, getting...
Quick links
Infographics
